Biotalys NV Actions au Porteur o.N. Logo
BE0974386188
A3CS50
BTLS.BR

Biotalys NV Actions au Porteur o.N.

Loading quotes...

Forecast

There is no analyst data available for this company.


  • Biotalys receives EPA approval for bio-fungicide Evoca and shares rise

    The US Environmental Protection Agency (EPA) has approved Biotalys's first bio-fungicide, Evoca, completing the regulatory review process. After the approval, Biotalys can submit registration applications in California and Florida, the main US growing regions for fruits and vegetables. Evoca targets fungal diseases such as Botrytis and powdery mildew; the company is also developing a more efficiently manufactured successor version (Evoca NG) with expected US approval in 2028/2029 and EU/Brazil approval in 2029/2030. » More on de.investing.com


  • Biotalys shares rise after positive EPA vote for Evoca

    Biotalys shares gained about 14% after the US Environmental Protection Agency (EPA) issued a proposed approval for the protein-based biofungicide Evoca. The EPA is thus initiating the final phase of the review process; stakeholders can comment within 15 days before the final decision is made. Evoca is seen as an important test for Biotalys’ business model; the company has production and distribution agreements with Novonesis and AgroFresh. Analysts at Kepler view the vote as a clear breakthrough for the investment case, also ahead of a possible EU approval. » More on de.investing.com

Financials

In the last quarter, Biotalys NV Actions au Porteur o.N. had revenue of €0 and net profit of -€4.57M
(EUR) June 2026
YoY
Revenue 0 100.00%
Gross profit 0 100.00%
Net profit -4.57M 12.39%
EBITDA -3.33M 8.33%

Fundamentals

Metric Value
Market capitalization
€106.79M
Number of shares
45.44M
52-week high/low
€5.28 - €1.56
Dividends No
Beta
1.37
P/E ratio
-5.34
PEG ratio
0.77
P/B ratio
6.17
P/S ratio
0.00

Company profile

Biotalys NV, ein Agrartechnologieunternehmen, erforscht und entwickelt neuartige biologische Produkte für den Schutz von Lebensmitteln und Nutzpflanzen. Das Unternehmen entwickelt hauptsächlich Biofungizide, Bioinsektizide und Biobakterizide. Das Unternehmen war früher unter dem Namen Agrosavfe NV bekannt. Biotalys NV wurde im Jahr 2013 gegründet und hat seinen Hauptsitz in Gent, Belgien.

Name
Biotalys NV Actions au Porteur o.N.
CEO
Carlo Boutton
Headquarters Gent,
Belgium
Website
IPO
07/02/2021
Employees 38

Ticker symbols

Exchange Symbol
Euronext
BTLS.BR
Brussels Stock Exchange
BTLS.BR
Frankfurt
86C.F
Düsseldorf
86C.DU
München
86C.MU
🍪

Parqet  uses cookies. Learn more